Global Insurer Shows Confidence in 2026 Performance Despite CEO Transition Announcement

Cigna Group (NYSE: CI) announced that David Cordani, its long‐time CEO, will step down and become Board Chair effective July 1, 2026. On the same date, Brian Evanko, currently President and COO, will be promoted to CEO and join the Board. The company also reaffirmed its previously issued 2026 guidance for adjusted earnings per share (EPS) of at least $30.25 and restated its pre‐tax adjusted profit targets for Evernorth Health Services and Cigna Healthcare.

On March 2 (local time) at the TD Cowen Healthcare Conference, Cigna reviewed its 2025 results and outlined its 2026 strategy, including plans to invest in a new rebate‐free pharmacy benefit management (PBM) model and reiterating its EPS outlook of at least $30.25 for 2026. Additionally, on March 19, 2025, Cigna completed the sale of its Medicare and CareAllies businesses to HCSC for approximately $3.7 billion, concluding a portfolio reshaping that focuses resources on Evernorth and its core commercial health insurance operations.

Headquartered in Connecticut, Cigna Group is a global health services and insurance company operating through two main segments: Evernorth Health Services and Cigna Healthcare. It ranks among the leading players in the U.S. managed care and PBM markets alongside UnitedHealth Group, CVS Health, and Elevance Health. The U.S. health insurance, pharmaceutical distribution, and PBM industries are currently experiencing consolidation and strategic realignment driven by an aging population, drug pricing regulations, and stricter insurance oversight.